CRISPR Therapeutics AG (CRSP)

64.66 +0.81 (+1.27%) USD  |  NASDAQ  |  May 26, 16:00
64.70 +0.04 (+0.06%) After-Hours: 20:00
More

CRISPR Therapeutics News

News

Headline
Wire
Time (ET)
Prediction: These 2 Stocks Could Double In the Next Year
Yahoo
05/28 10:15
3 No-Brainer Stocks to Buy for Under $100 Right Now
Yahoo
05/27 06:14
2 Supercharged Stocks to Buy With $100
Yahoo
05/27 05:30
2 Top Trends to Invest $5,000 in Right Now
Yahoo
05/25 09:40
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health
Yahoo
05/25 05:30
Citigroup Adjusts CRISPR Therapeutics' Price Target to $70 From $55, Keeps Neutral Rating
MT Newswires
05/23 08:16
CRISPR Therapeutics Stock Joins Rank Of Stocks With RS Ratings Over 90
Yahoo
05/23 03:00
Cathie Wood Just Sold CRISPR Therapeutics Stock. Here's Why You Should Consider Buying It
Yahoo
05/21 09:30
2 Stocks You'll Be Glad You Bought at These Prices
Yahoo
05/17 08:41
2 Soaring Growth Stocks That Could Rocket Even Higher
Yahoo
05/16 05:41
Why Are CRISPR Therapeutics Charts Saying 'Buy'?
Yahoo
05/15 13:00
Is CRISPR Therapeutics Stock a Buy Now?
Yahoo
05/13 08:45
--Morgan Stanley Adjusts Price Target on CRISPR Therapeutics to $42 From $39, Maintains Underweight Rating
MT Newswires
05/12 10:26
Why These 3 Nasdaq Stocks Were Glowing Green This Week
Yahoo
05/11 15:13
CRISPR Therapeutics Stock Sees Relative Strength Rating Rise To 89
Yahoo
05/10 10:53
CRISPR Therapeutics First Quarter 2023 Earnings: Beats Expectations
Yahoo
05/10 06:11
Why CRISPR Therapeutics Stock Is on Fire Today
Yahoo
05/09 14:25
--Stifel Adjusts Price Target on CRISPR Therapeutics to $64 From $69, Maintains Hold Rating
MT Newswires
05/09 09:32
--Credit Suisse Cuts CRISPR Therapeutics' Price Target to $62 From $65, Keeps Neutral Rating
MT Newswires
05/09 09:00
CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat
Yahoo
05/09 08:31
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Tops Revenue Estimates
Yahoo
05/08 17:15
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
Yahoo
05/08 16:01
1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May
Yahoo
05/04 10:38
3 Top Healthcare Stocks to Buy in May
Yahoo
05/04 05:30
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
Yahoo
05/02 12:49
CRISPR Therapeutics to Participate Upcoming Investor Conferences
Globe Newswire
05/02 08:00
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
Yahoo
05/02 05:53
Why the human genome could be health care’s holy grail
Yahoo
05/01 20:20
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
Yahoo
04/27 17:50
Insider Sell: Crispr Therapeutics
MT Newswires
04/27 17:40
Is It Too Late to Buy CRISPR Stock?
Yahoo
04/27 08:15
12 Gene Editing Stocks With the Best Long-Term Potential
Yahoo
04/26 14:10
Why CRISPR Therapeutics Just Became an Even Better Buy
Yahoo
04/26 10:07
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
Yahoo
04/25 06:00
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
Yahoo
04/24 18:00
The Best Stocks to Invest $20,000 in Right Now
Yahoo
04/23 14:00
Buy the Dip: 2 Top Stocks to Snatch Up Now
Yahoo
04/23 09:53
3 Stocks With Huge Catalysts on the Way
Yahoo
04/22 06:18
We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate
Yahoo
04/21 13:19
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
Yahoo
04/21 09:49
2 Growth Stocks That Could Keep Growing for Decades
Yahoo
04/21 07:30
Top 10 CRISPR Stocks To Buy
Yahoo
04/20 18:24
CRSP, OCUL and EYPT are among after hour movers
SA Breaking News
04/20 17:51
The Top 3 Biotech Stocks to Watch in 2023
Yahoo
04/20 10:07
3 High-Growth Biotech Stocks Poised for Success in 2023
Yahoo
04/18 06:40
The Top Healthcare Stocks to Buy With $100
Yahoo
04/18 05:30
Why CRISPR Therapeutics Stock Is Marching Higher Today
Yahoo
04/17 16:05
Why Shares of Editas Medicine Rose Monday
Yahoo
04/17 14:50
Better Growth Stock: Axsome vs. CRISPR Therapeutics
Yahoo
04/16 05:30
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know
Yahoo
04/14 18:00
Regulus (RGLS) Surges on Enrollment Completion for RGLS8429
Yahoo
04/14 12:49
Is CRISPR Therapeutics Stock a Buy Now?
Yahoo
04/14 10:23
Is BioRad Laboratories (BIO) Stock Outpacing Its Medical Peers This Year?
Yahoo
04/14 09:40
CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?
Yahoo
04/14 03:13
Hot Stocks: SPWH, INFY drop on earnings news; AU hits 52-week high on gold rally; CRSP soars
SA Breaking News
04/13 18:35
CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference
Globe Newswire
04/13 16:01
Crispr Therapeutics stock jumps following analyst upgrade from Cantor Fitzgerald
Yahoo
04/13 15:53
CRISPR Therapeutics Shares Rise After Cantor Fitzgerald Begins Coverage at Overweight
MT Newswires
04/13 13:13
Why Shares of CRISPR Therapeutics Jumped Thursday
Yahoo
04/13 11:58
CRISPR jumps 15% as Cantor issues bullish view citing exa-cel approval
SA Breaking News
04/13 10:40
2 Nasdaq Growth Stocks That Are Screaming Buys in April
Yahoo
04/13 10:15
Cantor Fitzgerald Starts CRISPR Therapeutics at Overweight With $72 Price Target
MT Newswires
04/13 06:57
These Up-and-Coming Stocks Are Screaming Buys Right Now
Yahoo
04/13 05:30
UPDATE 1-Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
Yahoo
04/12 18:10
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
Yahoo
04/12 17:31
Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a Bet
Yahoo
04/12 09:55
Could This Move Make Vertex's Next Blockbuster Even Bigger?
Yahoo
04/12 05:30
Pfizer CEO Albert Bourla backs FDA after abortion pill ruling
SA Breaking News
04/10 10:48
Where Will CRISPR Therapeutics Be in 5 Years?
Yahoo
04/09 07:45
CRISPR Stock: Bull vs. Bear
Yahoo
04/08 05:30
MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study
Yahoo
04/06 12:19
Here's Why You Should Add Ligand (LGND) Stock to Your Portfolio
Yahoo
04/06 10:23
What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio
Yahoo
04/06 08:00
AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal
Yahoo
04/05 12:25
VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans
Yahoo
04/05 11:42
2 Under-the-Radar Biotech Stocks to Buy in 2023
Yahoo
04/05 10:11
Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?
Yahoo
04/04 14:00
CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel
Yahoo
04/04 13:32
Ascendis (ASND) Down on Hypoparathyroidism Drug NDA Deficiencies
Yahoo
04/04 12:43
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
Yahoo
04/03 18:15
Vertex Pharmaceuticals, CRISPR Therapeutics Complete FDA Submission for Sickle Cell Disease, Thalassemia Treatment
MT Newswires
04/03 10:32
Emergent Biosciences (EBS) Surges 28% in a Week: Here's Why
Yahoo
04/03 08:57
Vertex, CRISPR finish rolling submission of application for sickle cell candidate
SA Breaking News
04/03 08:39
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Yahoo
04/03 08:00
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
Yahoo
04/01 05:30
Insider Sell: Crispr Therapeutics
MT Newswires
03/31 17:51
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors
Yahoo
03/31 09:00
5 Bargain-Basement Stocks to Buy Right Now
Yahoo
03/31 05:30
2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It
Yahoo
03/30 08:45
The 3 Best Growth Stocks to Buy in the Biotech Sector
Yahoo
03/29 22:23
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
Yahoo
03/29 20:54
12 Most Promising Healthcare Stocks According to Analysts
Yahoo
03/29 16:40
11 Most Promising Gene Editing Stocks According to Analysts
Yahoo
03/29 16:20
Biomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study
Yahoo
03/29 12:01
Is CRISPR Therapeutics (CRSP) Stock Outpacing Its Medical Peers This Year?
Yahoo
03/29 09:40
CRISPR Therapeutics Announces Departure of Board Member
Globe Newswire
03/29 08:00
Amicus (FOLD) Gets Pompe Disease Treatment Approval in Europe
Yahoo
03/28 11:04
Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug
Yahoo
03/28 10:41
Piper Sandler Adjusts CRISPR Therapeutics Price Target to $105 From $121, Maintains Overweight Rating
MT Newswires
03/27 13:12
Incyte's (INCY) Pemazyre Gets Approval to Treat MLNs in Japan
Yahoo
03/27 12:27
Vertex, CRISPR Sign Licensing Deal to Back Development of Vertex's Diabetes Treatment
MT Newswires
03/27 10:21
Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes
Yahoo
03/27 08:00
Could CRISPR Therapeutics Become the Next Moderna?
Yahoo
03/27 06:00
CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 5.1% decline adds to one-year losses, institutional investors may consider drastic measures
Yahoo
03/25 09:53
Could This Stock Become the Tesla of Its Industry?
Yahoo
03/25 09:30
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Yahoo
03/25 09:17
IOVA, BBIO and IREN are among after hour movers
SA Breaking News
03/24 17:28
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio
Yahoo
03/24 15:02
CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?
Yahoo
03/23 11:30
Biohaven (BHVN) Acquires Dual Inhibitor for Brain Disorders
Yahoo
03/23 11:09
This Cathie Wood Stock Could Nearly Double, According to Wall Street
Yahoo
03/23 10:07
Intellia's (NTLA) HAE Therapy Granted RMAT by the FDA
Yahoo
03/22 08:34
Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals
Yahoo
03/22 07:37
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
Yahoo
03/21 18:00
Here's Why You Should Add CRISPR Stock to Your Portfolio
Yahoo
03/21 11:59
FDA to back accelerated approval pathway for gene therapies
SA Breaking News
03/21 07:43
Bernstein Initiates CRISPR Therapeutics at Market Perform With $44 Price Target
MT Newswires
03/21 07:32
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
Yahoo
03/18 19:18
3 Beaten-Down Stocks That Could Soar This Year
Yahoo
03/18 06:14
Bellicum (BLCM) Down on Ending Development of CAR-T Candidates
Yahoo
03/16 11:41
CRISPR Therapeutics AG (CRSP) Stock Moves -0.51%: What You Should Know
Yahoo
03/15 18:00
Novo Nordisk (NVO) Follows Lilly, to Cut Insulin Prices by 75%
Yahoo
03/15 10:39
AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?
Yahoo
03/15 10:22
2 Top Biotech Stocks to Buy for the Long Haul
Yahoo
03/15 05:30
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
Yahoo
03/14 18:15
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting
Globe Newswire
03/14 18:02
CRISPR Therapeutics Names Raju Prasad as Chief Financial Officer
MT Newswires
03/13 17:16
CRISPR Therapeutics Announces Transition of Chief Financial Officer
Yahoo
03/13 16:15
Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret
Yahoo
03/13 11:39
Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?
Yahoo
03/13 09:40
Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan
Yahoo
03/10 10:42
AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies
Yahoo
03/10 10:26
If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today
Yahoo
03/10 08:15
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
Yahoo
03/09 08:50
2 Healthcare Stocks That Could Help Make You a Fortune
Yahoo
03/08 14:00
7 Cathie Wood Stocks for Your March Buy List
Yahoo
03/07 14:48
Baird Starts CRISPR Therapeutics at Neutral With $46 Price Target
MT Newswires
03/07 08:45
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
Yahoo
03/06 12:13
Better Growth Stock: Moderna vs. CRISPR Therapeutics
Yahoo
03/05 05:30
3 Things About CRISPR Therapeutics That Smart Investors Know
Yahoo
03/04 07:25
3 Game-Changing Stocks to Buy in March
Yahoo
03/04 06:14
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
Yahoo
03/03 09:15
Insider Sell: Crispr Therapeutics
MT Newswires
03/02 00:33
Theravance's (TBPH) Q4 Earnings and Revenues Miss Estimates
Yahoo
02/28 14:17
Morgan Stanley Adjusts Price Target on CRISPR Therapeutics to $39 From $37, Maintains Underweight Rating
MT Newswires
02/27 10:03
Oppenheimer Adjusts CRISPR Therapeutics Price Target to $102.06 From $110, Maintains Outperform Rating
MT Newswires
02/23 08:44
Sector Update: Health Care Stocks Finish With Slim Declines
MT Newswires
02/22 16:06
Sector Update: Health Care Stocks Rising Modestly Wednesday Afternoon
MT Newswires
02/22 14:23
Update: CRISPR Therapeutics Shares Rise Wednesday After Company Posts Narrowed Q4 Net Loss
MT Newswires
02/22 13:29
CRISPR surges 14% most in over two years after Q4 earnings
SA Breaking News
02/22 13:29
Needham Lowers Price Target on CRISPR Therapeutics to $82 From $122, Keeps Buy Rating
MT Newswires
02/22 09:37
Credit Suisse Adjusts Price Target on CRISPR Therapeutics to $65 From $78, Maintains Neutral Rating
MT Newswires
02/22 08:59
Chardan Adjusts Price Target on CRISPR Therapeutics to $123 From $153, Keeps Buy Rating
MT Newswires
02/22 08:04
CRISPR Therapeutics AG's Q4 Net Loss a Share Narrows
MT Newswires
02/21 16:42
JMP Securities Adjusts Price Target on CRISPR Therapeutics to $70 From $100, Maintains Market Outperform Rating
MT Newswires
01/19 08:43
CRISPR Therapeutics to Participate in B. Riley Securities’ 3rd Annual Oncology Conference
Globe Newswire
01/11 08:00
EF Hutton Starts CRISPR Therapeutics at Buy With $75 Price Target
MT Newswires
01/05 07:48
CRSP, ARCT and CHRS are among after hour mover
SA Breaking News
01/03 18:01
Insider Sell: Crispr Therapeutics
MT Newswires
01/03 07:24
CRSP, CERS and SITM are among after hours mover
SA Breaking News
12/14 18:08
CRISPR Therapeutics Says Updated Data from Phase 1 Trial Show CTX110 Leads to Long-term Complete Remissions in Large B-cell Lymphoma
MT Newswires
12/12 16:12
CRISPR Therapeutics Provides Update on Its Ongoing Phase 1 CARBON™ Trial of CTX110®
Globe Newswire
12/12 10:00
CRISPR Therapeutics to Present at the 2022 BMO Growth & ESG Conference
Globe Newswire
12/01 08:00
Insider Sell: Crispr Therapeutics Ag
MT Newswires
11/30 17:43
Citigroup Adjusts Price Target on CRISPR Therapeutics AG to $63 From $83, Maintains Neutral Rating
MT Newswires
11/23 09:43
--SVB Leerink Adjusts Price Target on CRISPR Therapeutics AG to $76 From $75, Maintains Outperform Rating
MT Newswires
11/07 09:31
--Oppenheimer Adjusts CRISPR Therapeutics Price Target to $110 From $122, Maintains Outperform Rating
MT Newswires
11/03 10:11
--Credit Suisse Lowers CRISPR Therapeutics' Price Target to $78 From $90, Keeps Neutral Rating
MT Newswires
11/02 11:28
--RBC Lowers CRISPR Therapeutics' Price Target to $70 From $79, Keeps Sector Perform Speculative Risk Rating
MT Newswires
11/02 10:11
--Chardan Trims Price Target for CRISPR Therapeutics to $153 from $154, Keeps Buy Rating
MT Newswires
11/02 08:27
CRISPR Therapeutics Net Loss Widens as Q3 After Revenue Slumps
MT Newswires
11/01 16:27
-- Earnings Flash (CRSP) CRISPR THERAPEUTICS Reports Q3 Revenue $94M
MT Newswires
11/01 16:04
-- Earnings Flash (CRSP) CRISPR THERAPEUTICS Posts Q3 Loss $-2.24
MT Newswires
11/01 16:04
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
Globe Newswire
11/01 16:01
CRISPR Therapeutics Chief Operating Officer Lawrence Klein to Step Down
MT Newswires
10/27 11:55
CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer
Globe Newswire
10/27 08:30
TTD, CRSP and MUX are among after hour movers
SA Breaking News
10/20 18:01
--Morgan Stanley Starts CRISPR Therapeutics at Underweight With $37 Price Target
MT Newswires
10/11 09:12
Svante Pääbo gets Nobel Prize for Medicine for discoveries on genome, human evolution
SA Breaking News
10/03 06:14
Insider Sell: Crispr Therapeutics
MT Newswires
09/30 17:47
CRISPR Therapeutics to Present at the BMO Biopharma Spotlight Series: Gene Editing and Therapy
Globe Newswire
09/29 08:00
CRISPR Therapeutics Says US FDA Grants Regenerative Medicine Advanced Therapy Designation to CTX130
MT Newswires
09/28 10:15
Equities Set New 2022 Lows as Consumer Confidence, New-Home Sales Beat Views
MT Newswires
09/27 13:30
Midday Report: US Stocks Set New 2022 Lows as Consumer Confidence, New-Home Sales Beat; 10-Year Yield Just Under 4%
MT Newswires
09/27 13:29
Vertex, CRISPR Say FDA Grants Rolling Review to Exa-Cel to Treat Sickle Cell Disease, Beta Thalassemia
MT Newswires
09/27 10:53
Insider Sell: Crispr Therapeutics
MT Newswires
08/31 17:51
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire
08/31 08:00
CRISPR Therapeutics falls as Barclays downgrades after Q2 update
SA Breaking News
08/09 14:28
--Stifel Nicolaus Adjusts CRISPR Therapeutics Price Target to $69 From $55, Maintains Hold Rating
MT Newswires
08/09 12:10
--Goldman Sachs Raises CRISPR Therapeutics AG's Price Target to $50 From $46, Keeps Neutral Rating
MT Newswires
08/09 10:41
--Credit Suisse Raises CRISPR Therapeutics' Price Target to $90 from $74 Based on Discounted Cash Flow, Maintains Neutral Rating
MT Newswires
08/09 09:59
--RBC Cuts Price Target on CRISPR Therapeutics to $79 From $85, Maintains Sector Perform Rating, Speculative Risk Qualifier
MT Newswires
08/09 07:53
--Barclays Cuts CRISPR Therapeutics to Equalweight From Overweight, Price Target to $88 From $99
MT Newswires
08/09 06:33
--Chardan Research Adjusts CRISPR Therapeutics' Price Target to $154 From $164, Reiterates Buy Rating
MT Newswires
08/09 05:15
CRISPR Therapeutics Swings to Q2 Loss
MT Newswires
08/08 08:31
-- Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q2 Revenue $158,000
MT Newswires
08/08 08:04
-- Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Posts Q2 Loss $-2.40
MT Newswires
08/08 08:03
--Citigroup Adjusts Price Target on CRISPR Therapeutics to $83 From $53, Maintains Neutral Rating
MT Newswires
08/02 09:12
Insider Sell: Crispr Therapeutics
MT Newswires
07/29 17:42
Insider Sell: Crispr Therapeutics
MT Newswires
07/05 07:25
Oppenheimer Adjusts CRISPR Therapeutics Price Target to $122 From $150, Maintains Outperform Rating
MT Newswires
06/23 11:48
Evercore ISI Downgrades CRISPR Therapeutics to In Line From Outperform, Lowers Price Target to $60 From $66
MT Newswires
06/23 09:20
CRISPR stock extends Innovation Day slump despite bullish views
SA Breaking News
06/22 12:28
22nd Century, Wave Life top healthcare gainers; while Athira, Neptune Wellness lead losers' pack
SA Breaking News
06/22 10:03
Chardan Adjusts CRISPR Therapeutics' Price Target to $164 from $168, Keeps Buy Rating
MT Newswires
06/22 09:49
Stifel Adjusts CRISPR Therapeutics' Price Target to $55 from $57, Keeps Hold Rating
MT Newswires
06/22 08:43
Piper Sandler Adjusts Price Target on CRISPR Therapeutics to $121 From $115, Reiterates Overweight Rating
MT Newswires
06/22 05:07
Catalyst watch: FedEx earnings, Revlon drama and huge Polestar SPAC deal goes to a vote
SA Breaking News
06/17 15:00
Crispr Therapeutics Shares Rise After BMO Capital Begins Coverage at Outperform
MT Newswires
06/17 13:23
--BMO Capital Initiates Coverage of CRISPR Therapeutics AG with Outperform Rating, $98 Price Target
MT Newswires
06/16 16:25
Crispr falls 12% most since 2020 as rival wins FDA backing for beta thalassemia drug
SA Breaking News
06/13 13:44
Stifel Adjusts Price Target on CRISPR Therapeutics to $57 From $52, Reiterates Hold Rating
MT Newswires
06/13 07:58
CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT™-LYM Trial of CTX130™ in Relapsed or Refractory T Cell Malignancies at the 2022 European Hematology Association (EHA) Congress
Globe Newswire
06/11 11:00
Vertex, CRISPR update long-term data for gene edited therapy in blood disorders
SA Breaking News
06/11 08:51
CRISPR Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
Globe Newswire
06/08 08:00
CRISPR Therapeutics to Host Innovation Day on June 21, 2022
Globe Newswire
05/31 08:00
Goldman Sachs Adjusts CRISPR Therapeutics' Price Target to $46 from $52, Keeps Neutral Rating
MT Newswires
05/24 10:50
CRISPR, Xencor stock falls as Piper Sandler slashes price target in biotech space
SA Breaking News
05/23 12:58
Piper Sandler Lowers CRISPR Therapeutics AG's Price Target to $115 From $180, Overweight Rating Kept
MT Newswires
05/23 09:55
Citigroup Adjusts Price Target on CRISPR Therapeutics to $53 From $64, Maintains Neutral Rating
MT Newswires
05/17 06:04
CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer
Globe Newswire
05/16 16:01
Needham Adjusts Price Target on CRISPR Therapeutics to $122 From $170, Keeps Buy Rating
MT Newswires
05/13 05:18
Sector Update: Health Care Stocks Close Higher on Thursday
MT Newswires
05/12 16:11
CRISPR Therapeutics Says T-Cell Lymphoma Therapy Trial Shows 'Clinically Meaningful' Responses
MT Newswires
05/12 12:29
CRISPR Therapeutics Announces Oral Presentation of New Clinical Data on Anti-CD70 Allogeneic CAR-T Therapy CTX130™ for Patients with T-cell Lymphoma at the Annual European Hematology Association (EHA) 2022 Hybrid Congress
Globe Newswire
05/12 10:33
--JMP Securities Lowers CRISPR Therapeutics AG's Price Target to $100 From $150, Maintains Market Outperform Rating
MT Newswires
05/11 11:19
--Oppenheimer Adjusts CRISPR Therapeutics Price Target to $150 From $172, Maintains Outperform Rating
MT Newswires
05/11 10:46
--Stifel Nicolaus Adjusts Price Target for CRISPR Therapeutics AG to $52 From $64, Maintains Hold Rating
MT Newswires
05/10 14:00
--Chardan Lowers CRISPR Therapeutics AG's Price Target to $168 From $171, Maintains Buy Rating
MT Newswires
05/10 11:27
CRISPR stock draws flurry of price target cuts following Q1 result
SA Breaking News
05/10 09:43
--SVB Securities Adjusts CRISPR Therapeutics' Price Target to $112 from $120, Keeps Outperform Rating
MT Newswires
05/10 08:59
--Barclays Adjusts CRISPR Therapeutics' Price Target to $99 From $107, Reiterates Overweight Rating
MT Newswires
05/10 08:23
--RBC Cuts Price Target on CRISPR Therapeutics to $85 From $95, Maintains Sector Perform-Speculative Risk Rating
MT Newswires
05/10 08:01
--Chardan Research Adjusts Price Target on CRISPR Therapeutics to $168 From $171 After Q1 Report; Buy Rating Kept
MT Newswires
05/10 04:51
-- Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q1 Revenue $940,000
MT Newswires
05/09 16:03
-- Earnings Flash (CRSP) CRISPR THERAPEUTICS AG Reports Q1 Loss $-2.32
MT Newswires
05/09 16:03
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results
Globe Newswire
05/09 16:01
--Credit Suisse Initiates Crispr Therapeutics at Neutral, $78 Price Target
MT Newswires
04/28 11:07
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
Globe Newswire
04/12 16:01
SPI, WDAY, CRSP and IMGN among after hour movers
SA Breaking News
04/01 18:02
LFLY, CARA and CRSP among after hour movers
SA Breaking News
03/24 18:25
Citigroup Adjusts Price Target on CRISPR Therapeutics to $64 From $90, Maintains Neutral Rating
MT Newswires
03/15 09:30
CRSP, GILT and SDIG among after hour movers
SA Breaking News
03/11 17:47
CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2022 Annual Meeting
Globe Newswire
03/08 16:35
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire
02/28 08:00
Goldman Sachs Adjusts CRISPR Therapeutics Price Target to $87 From $179, Maintains Neutral Rating
MT Newswires
02/16 10:10
Barclays Adjusts CRISPR Therapeutics Price Target to $107 From $148, Maintains Overweight Rating
MT Newswires
02/16 10:10
JMP Securities Adjusts CRISPR Therapeutics Price Target to $150 From $155, Maintains Market Outperform Rating
MT Newswires
02/16 10:10
SVB Leerink Adjusts CRISPR Therapeutics' Price Target to $120 from $126, Maintains Outperform Rating
MT Newswires
02/16 09:05
RBC Cuts Price Target on CRISPR Therapeutics to $95 From $117, Citing Higher Research & Development Burn; Sector Perform-Speculative Risk Rating Kept
MT Newswires
02/16 08:07